低强度体外冲击波治疗改善链脲佐菌素诱导的糖尿病大鼠膀胱活动低下
本研究在链脲佐菌素诱导的糖尿病大鼠模型中评估每周一次低强度体外冲击波治疗(Li-ESWT)对膀胱活动低下(UAB)的疗效。结果显示Li-ESWT显著改善排尿功能,表现为残余尿量减少和漏尿点压力增加,并恢复膀胱和尿道结构与功能。Li-ESWT无创,可能成为UAB的替代疗法,但需进一步研究。
要点
- Li-ESWT改善糖尿病UAB大鼠的排尿功能,减少残余尿并增加漏尿点压力。
- Li-ESWT恢复膀胱和尿道收缩功能及组织结构,并修复神经完整性。
- Li-ESWT无创,可能成为UAB的替代疗法,但需进一步临床研究。
核心结论
- 在糖尿病UAB大鼠模型中,Li-ESWT改善膀胱活动低下和尿失禁,可能通过恢复膀胱和尿道结构与功能实现。
研究设计与样本
- 研究纳入36只雌性Sprague-Dawley大鼠,分为正常对照组、糖尿病对照组和糖尿病Li-ESWT组。
- 糖尿病组腹腔注射60 mg/kg链脲佐菌素诱导糖尿病,Li-ESWT于给药4周后开始,每周一次,持续4周,能量通量密度0.02 mJ/mm2,频率3 Hz,400脉冲。
主要发现
- 糖尿病对照组出现排尿功能障碍,而Li-ESWT组残余尿量减少、漏尿点压力增加。
- 离体器官浴实验显示Li-ESWT增强电场和药物刺激下膀胱和尿道的肌肉收缩活动。
- 组织学显示Li-ESWT减少膀胱腔内面积并增加膀胱壁肌肉比例。
- Western Blot显示Li-ESWT组膀胱壁平滑肌肌动蛋白表达高于糖尿病对照组。
- 免疫荧光显示糖尿病对照组神经末梢分布减少、神经纤维破坏缩短,Li-ESWT组神经完整性和支配恢复。
临床怎么用
- Li-ESWT作为一种无创疗法,可能为糖尿病相关UAB提供替代治疗选择,但当前证据限于动物模型,临床应用需进一步验证。
局限性
- 研究为动物实验,结果能否推广至人类尚需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To evaluate the therapeutic effect of once-weekly low-intensity extracorporeal shock wave therapy (Li-ESWT) on underactive bladder (UAB) in the streptozotocin (STZ)-induced diabetic rat model. MATERIALS AND METHODS: In all, 36 female Sprague-Dawley rats were divided into three groups: normal control (NC), diabetes mellitus control (DMC), and DM with Li-ESWT (DM Li-ESWT). The two DM groups received an intraperitoneal 60 mg/kg STZ injection to induce DM. The Li-ESWT was applied toward the pelvis of the rats starting 4 weeks after STZ administration and lasting for 4 weeks. The Li-ESWT was given once weekly, with an energy flux density of 0.02 mJ/mm2 at 3 Hz for 400 pulses. All rats underwent conscious cystometry, leak-point pressure (LPP) assessment, ex vivo organ-bath study, histology, immunofluorescence, and Western Blot analysis. RESULTS: Conscious cystometry revealed voiding dysfunction in the DMC group, whereas the DM Li-ESWT group showed significantly improved voiding function, reflected in a reduced post-void residual urine volume and increased LPP compared to the DMC group. Ex vivo organ-bath studies showed that Li-ESWT enhanced muscle contractile activity of the bladder and urethra during electrical-field stimulation and drug stimulation. Histologically, Li-ESWT significantly restored bladder morphology, reflected by a reduction in the intravesical lumen area and increased muscle proportion of the bladder wall. Western Blot analysis showed higher smooth muscle actin expression in the bladder wall in the DM Li-ESWT group compared to the DMC group. Immunofluorescence showed decreased nerve-ending distribution, and destroyed and shortened nerve fibres in the DMC group, and recovery of neuronal integrity and innervation in the DM Li-ESWT group. CONCLUSIONS: In conclusion, Li-ESWT ameliorated UAB and urinary incontinence in the diabetic UAB rat model. The improvement appears to be the result of restoration of bladder and urethral structure and function by Li-ESWT. Li-ESWT is non-invasive and may become a better alternative therapy for UAB. Further investigations are warranted.
引用
- Wang HS, Oh BS, Wang B, et al. Low-intensity extracorporeal shockwave therapy ameliorates diabetic underactive bladder in streptozotocin-induced diabetic rats. BJU Int. 2018. PMID: 29603534. doi:10.1111/bju.14216
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。